This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
A meeting by a panel of science advisors to choose flu strains to include in a v...
The use of a subset of common diabetes drugs skyrocketed in the US Medicare prog...
Eli Lilly touted a huge new US manufacturing investment at an event in Washingto...
Regeneron is now expecting an accelerated approval decision this summer on its T...
AstraZeneca wasn't expected to have data from the Phase 3 trial of its oral SERD...
Several small clinical trials have demonstrated that gene therapies have restore...
Plus, news about Idorsia, Enveda, Zymeworks, BerGenBio and Ignota Labs: Harb...
Eli Lilly is continuing to invest big in US pharma manufacturing, with the addit...
Merck said its “once-in-a-lifetime” drug Keytruda could be subject to price redu...
One of biotech's best-funded startups has just raised a huge new round to take i...
Ginkgo Bioworks’ stock $DNA fell by around 13% premarket Wednesday after the com...
The Federal Trade Commission is continuing its investigation into anticompetitiv...
For the first time since 2018, dermatology-focused Leo Pharma forecasts it could...
To Candel Therapeutics CEO Paul Peter Tak, the biotech’s viral immunotherapy has...
Drug compounders have sued the FDA to put the weight loss and diabetes drug sema...
Emalex Biosciences said its daily oral tablet helped reduce relapses for childre...